Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Osman Sütcüoğlu"'
Autor:
Orhun Akdogan, Betul Ogut, Osman Sutcuoglu, Aysenur Sert, Fatih Gurler, Nalan Akyurek, Nuriye Ozdemir, Ahmet Ozet, Ozan Yazici
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Growth differentiation factor-15 (GDF-15), a member of the TGF-β superfamily, is overexpressed in various cancers and facilitates immune evasion by inhibiting T-cell activation. GDFATHER-TRIAL’s phase 2a results demonstrated pr
Externí odkaz:
https://doaj.org/article/db4a573e19b24f1c82b55dbc73a1b3e1
Autor:
Fatih Kus MD, Deniz Can Guven PhD, Hasan Cagri Yildirim PhD, Baran Akagunduz PhD, Serdar Karakaya PhD, Osman Sutcuoglu PhD, Elvin Chalabiyev MD, Arif Akyildiz MD, Baris Koksal MD, Yigit Berk Sahin MD, Ece Karaca MD, Oguz Alp Kavruk MD, Nefise Tugce Zor MD, Firat Sirvan MD, Ozan Yazici PhD, Suayib Yalcin PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Aims: This study aimed to assess the habits and knowledge of cancer patients regarding the use of herbal medicines and dietary supplements in cancer patients receiving immune checkpoint inhibitors (ICI). Methods: The data of 181 cancer patients who w
Externí odkaz:
https://doaj.org/article/171b5c2135e74f2db40143086b69d588
Autor:
Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, Tahir Yerlikaya, Engin Hendem, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Şahin, Teoman Şakalar, Nilay Şengül Samancı, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algın, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Berna Öksüzoğlu, Aydın Yavuz, Osman Yüksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Özdemir
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Neoadjuvant treatment is the standard treatment in locally advanced ESCC. However, the optimal chemotherapy regimen is not known. Method This is a retrospective observational cohort study conducted with propensity score matching.
Externí odkaz:
https://doaj.org/article/0c2407cd5a0448378847928577fc42af
Autor:
OSMAN SÜTCÜOĞLU, ZEYNEP SEZGİ ERDAL, ORHUN AKDOĞAN, EMRAH ÇELTİKÇİ, NURİYE ÖZDEMİR, AHMET ÖZET, MURAT UÇAR, OZAN YAZICI
Publikováno v:
Turkish Journal of Medical Sciences. 53:420-431
Autor:
Osman SÜTCÜOĞLU, Mehmet Arda İNAN, Aytuğ ÜNER, Gözde SAVAŞ, Hüseyin BORA, Ahmet ÖZET, Nazan GÜNEL, Nalan AKYÜREK, Ozan YAZICI, Nuriye ÖZDEMİR
Publikováno v:
Journal of Oncological Sciences. 9:23-32
Publikováno v:
Indian Journal of Gynecologic Oncology. 21
Autor:
Görkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, Deniz Can Güven, Altan Kavuncuoğlu, Nuriye Özdemir, Ahmet Özet, Sercan Aksoy, Yeşim Gaye Güler Tezel, Nalan Akyürek, Ozan Yazıcı
Publikováno v:
Strahlentherapie und Onkologie.
Publikováno v:
Journal of Gastrointestinal Cancer.
Autor:
Kadriye Bir Yücel, Zeynep Irem Özay, Osman Sütcüoğlu, Ozan Yazıcı, Aytug Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Özdemir
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.Purpose: This study aims to investigate the factors that influence financial toxicity and its effects on both quality of life and psychological d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846948938be585238e88a064fa163b2a
https://avesis.gazi.edu.tr/publication/details/666bd8c7-fd33-43bc-bcd6-d73262425701/oai
https://avesis.gazi.edu.tr/publication/details/666bd8c7-fd33-43bc-bcd6-d73262425701/oai
Autor:
Nuriye Ozdemir, Irem Bilgetekin, Esra Zeynelgil, Mustafa Altinbaş, Ismail Erturk, Selin Akturk Esen, Dogan Uncu, Musa Baris Aykan, Goksen Inanc Imamoglu, Yeşim Yıldız, Cengiz Karacin, Ahmet Ozet, Burak Civelek, Ismail Celik, Gokhan Ucar, Fatma Buğdaycı Başal, Nuri Karadurmus, Ozan Yazıcı, Bedia Dinc, Ibrahim Karadag, Omur Berna Oksuzoglu, Osman Sütcüoğlu, Yakup Ergun, Mutlu Dogan, Tulay Eren
Publikováno v:
Future Oncology
Aim: To evaluate the immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Methods: This multicenter, prospective, observational study was conducted with 47 patients receiving active systemic th